pcn Q&As

Q&As

Addressing Common Clinical Challenges in ADHD Treatment

09/08/2023

Julie A. Carbray , PhD, APRN;

Julie Carbray, PhD, APRN, discusses her Psych Congress 2023 session on optimizing ADHD treatment.

Julie Carbray, PhD, APRN,...

09/08/2023

Psych Congress Network

Q&As

Depressive Mixed States: Diagnosis, Treatment, and Strategies

09/07/2023

Mark Zimmerman , MD;

Depressive Mixed States (DMX) is a new specifier listed in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), and describes when patients experience both depressive symptoms and symptoms of mania or hypomania...

Depressive Mixed States (DMX) is...

09/07/2023

Psych Congress Network

Q&As

Ketamine Treatment in TRD Should Last 4 Weeks or More for Antidepressant Benefit

07/21/2023

Colleen Loo , MBBS, MD;

Colleen Loo, MBBS, FRANZCP, MD, lead researcher of a groundbreaking study on the use of subcutaneous racemic ketamine for TRD, shares the rationale behind the study, its major findings, practical implications, and more.

Colleen Loo, MBBS, FRANZCP, MD,...

07/21/2023

Psych Congress Network

Q&As

Exploring Novel and Accessible Treatment Approaches for Children With Depression, Part 1

07/17/2023

Parco Sui, PhD, associate professor and head of the Kinesiology Division at the University of Hong Kong discusses the results of his study "Physical Activity Interventions to Alleviate Depressive Symptoms in Children and Adolescents."

Parco Sui, PhD, associate...

07/17/2023

Psych Congress Network

Q&As

Using Physical Activity to Improve Adolescents' MDD Symptoms

07/17/2023

In part 2 of this Q&A, Parco Sui, PhD, associate professor and head of the Kinesiology Division at the University of Hong Kong reveals the clinical implications of his study "Physical Activity Interventions to Alleviate Depressive Symptoms in...

In part 2 of this Q&A, Parco...

07/17/2023

Psych Congress Network

Q&As

Speech, Language Assessment Useful in Schizophrenia Spectrum Disorders Treatment

06/09/2023

Sunny Tang, MD, and Michael Spilka, PhD, share how natural language processing (NLP) can be useful in treating schizophrenia.

Sunny Tang, MD, and Michael...

06/09/2023

Psych Congress Network

Q&As

Psychedelics: A Unique Psychiatric Paradigm

06/04/2023

A behind-the-scenes look into the Psych Congress Elevate session, the history of psychedelics, and why psychedelics represent a "unique psychiatric paradigm."

A behind-the-scenes look into...

06/04/2023

Psych Congress Network

Q&As

Utilizing Trauma-Informed Approaches for Collaborative and Empowering Care

06/02/2023

The latest coverage from Psych Congress Elevate 2023 in Las Vegas, Nevada.

The latest coverage from Psych...

06/02/2023

Psych Congress Network

Q&As

"Good Psychiatric Management" Effective in Borderline Personality Disorder Treatment, Dr Mark Zimmerman Says

06/01/2023

Ahead of his Psych Congress Elevate session Mark Zimmerman, MD, shares why borderline personality disorder (BPD) is often underdiagnosed, how clinicians can screen for it, and psychopharmacological treatment of the disorder.

Ahead of his Psych Congress...

06/01/2023

Psych Congress Network

Q&As

How Advanced Practice Providers can Tailor Individual Depression Treatment

04/30/2023

Andrew Penn, MS, PMHNP, discusses key takeaways from his session on prescribing antidepressants.

Andrew Penn, MS, PMHNP,...

04/30/2023

Psych Congress Network

Q&As

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

Sign Up

Specialties

Events

Year Round Education

HMP Global Products